Hello. Would it be possible to get more details about what your advantages are compared to potential competitors such as Demetrix and Cronos group? It seems these other companies also use yeast. What are you doing differently and why do you think it would give you an edge over...

The information about each competitor is limited and our judgment is coming from publicly available information. The point below could be wrong due to limited information to the current stage of R&D by competitors. Demetrix: 1. they are using a baker's yeast (Saccharomyces cerevisiae) for production which has significantly fewer precursors (Acetyl-CoA). 2. They are using gene csPT4 for the production of CBGA. This gene is not specific. It is producing not only CBGA but also sesqui-CBGA. 3...

Does your company operate in a cGMP or better manufacturing facility? What is the size is the facility you are using for manufacturing, labs, R&D etc?

we are not in the production stage yet. We don't have cGMP facility yet. We are using 8,000 sqft facility in Fremont, CA. Once we begin large scale production in early 2022 it will be in a GMP certified facility

Where can I find your SEC filings? Financial Information?

We have just filed with the SEC. The financial info will be available in the next couple of days. I will update you once it's public.

Can't find it anywhere , what's the per share cost?

The share price is $4.50. We are hoping and planning on going public next year at a much higher price. 10-15 dollars but there are no guarantees that we will be able to do so. We are very confident though

Hi team, I'm interested in investing $10k in this project but could you elaborate a bit on what the investors get in return for their investment? Is it a convertible note or what tool? thanks!

The share price is $4.50. We are hoping and planning on going public next year at a much higher price. 10-15 dollars but there are no guarantees that we will be able to do so. We are very confident though.

Biomedican inc

Producing medical-grade cannabis more efficiently

Pitch Video

Investor Panel

biomedican.com

Fremont, CA

Technology B2B Health & Fitness Science & R&D

Investor Panel

Shu interviewed Biomedican inc on July 19, 2021. Play Video

Shu Li

CEO and co-founder of Petri-Bio

Strengths

says, "This company has a very unique solution to bring high-quality, low-cost CBD products to the market with fewer regulatory hurdles. I think that's a very exciting project"

Advice

says, "I'm very fascinated by how this biosynthesis product also remains organic. I think the audience would enjoy learning it too. Would be helpful to give more information on the campaign page"

What Investors Say

What People Say

Biomedican inc

Quick facts

Team profiles

Featured investor profiles

$220,467

Investor Panel

What Investors Say